Physician profile
Kyle Keyes
NPI 1982963864
$58,377.03
in general payments reported to CMS, 2019-2025
32 companies · $9,505 in 2025
The $9,505 reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $24.29 · 2021: $42.93 · 2022: $247 · 2023: $31K · 2024: $18K · 2025: $9,505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $44K · Travel and Lodging: $8,436 · Food and Beverage: $5,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $44,000.00 |
| Travel and Lodging | $8,436.19 |
| Food and Beverage | $5,412.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $55,944.61 | 2022-2025 | Da Vinci Surgical System |
| Abbvie INC. | $436.80 | 2023-2025 | |
| Boston Scientific Corporation | $285.09 | 2019-2024 | Rezum Generator, Spaceoar Vue System - 10ml |
| Medtronic, INC. | $265.32 | 2021-2023 | Intellis Adaptivestim |
| 180 Medical, INC. | $145.60 | 2023-2024 | Gentlecath Glide |
| Ferring Pharmaceuticals INC. | $145.15 | 2024-2025 | Adstiladrin |
| Teleflex LLC | $133.84 | 2022-2025 | Urolift, Barrigel |
| Sumitomo Pharma America, INC. | $118.85 | 2023-2025 | Orgovyx |
| Procept Biorobotics Corporation | $78.16 | 2025 | |
| Coloplast Corp | $74.09 | 2021-2024 | Altis |
| Pfizer INC. | $69.76 | 2019-2025 | |
| Biotissue Holdings INC. | $68.74 | 2025 | |
| Laborie Medical Technologies Corp. | $64.63 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Urogen Pharma, INC. | $64.17 | 2023-2025 | Jelmyto |
| Bayer Healthcare Pharmaceuticals INC. | $54.80 | 2024-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $48.65 | 2019 | |
| Endo Pharmaceuticals INC. | $43.08 | 2023-2024 | Xiaflex, Aveed |
| Endo USA, INC. | $39.89 | 2024-2025 | Xiaflex, Aveed |
| Cook Medical LLC | $31.51 | 2019 | |
| Convatec INC. | $27.93 | 2023 | |
| Novartis Pharmaceuticals Corporation | $27.58 | 2023 | |
| Neotract INC. | $24.29 | 2020 | |
| Argon Medical Devices, INC. | $23.71 | 2024 | Clot Management |
| Smith+Nephew, INC. | $23.24 | 2023 | Stravix Pl |
| Astellas Pharma US INC | $21.21 | 2023 | Xtandi |
| Accord Healthcare, INC. | $19.71 | 2023 | |
| Immunitybio, INC. | $17.55 | 2025 | |
| Janssen Biotech, INC. | $16.74 | 2025 | Erleada |
| Halozyme INC | $15.99 | 2023 | |
| Valencia Technologies Corporation | $15.77 | 2023 | Ecoin Device Kit |
| Myriad Genetic Laboratories, INC. | $15.70 | 2023 | Prolaris |
| Palette Life Sciences, INC. | $14.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Keyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.